Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > One man pump show failing ….

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon Jun 24, 2021 12:42pm

50 Views

Post# 33444398

RE:One man pump show failing ….

it's funny cause it's so true! Poor little pumper thinks that his nonsense actually influences people to invest into this train wreck created by Thomvest
Kur flush! Lol

stockbuphoon wrote:

Tommyjones, Newcamo Realstocky - price target, GO, GO, GO
$100, no wait $50, no wait $25, no wait, $20, $15, $12, $10, $8, wait $6 anything, please....

how about lmnl management put together a plan other than pulling lead indicators of their lead small molecule program. What are they scared of?

it's under $4 again and there is no plan for execution except cash a voucher.

they are tanking this puppy. They don't explain anything. How else would the stock perform?